Back
2007N-0382
C 3
Volume 1
Comment
Tab 1 -
SEC Form 10-Q, Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934, Commission File No. 001-15875,
King Pharmaceuticals, Inc.
Tab
2 - U.S. Court of Appeals for the Federal Circuit, Aventis &
King Pharmaceuticals v Lupin Ltd., Appeal No. 2006-1530, -1555 (Fed.
Cir. Sept. 11, 2007)
Tab 3
- Aventis Pharma v Cobalt Pharmaceuticals, Civil Action No. 03-10492
JLT
Top | Back
Page last updated
October 29, 2007
RSC
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |